raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:270

Oculopharyngeal muscular dystrophy

Synonyms: OPMD

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant, Autosomal recessive
Age of onset
Adult, Elderly
Status
active

A rare, adult-onset, progressive myopathy characterized by progressive eyelid ptosis, ophthalmoplegia, dysphagia, dysarthria and proximal limb weakness.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enOculopharyngeal muscular dystrophyOPMD
frDystrophie musculaire oculo-pharyngéeDMOP · OPMD
deMuskeldystrophie, okulopharyngeale= en
esDistrofia muscular oculofaríngeaDMOF
itDistrofia muscolare oculofaringea= en
nlOculofaryngeale spierdystrofie= en
ptDistrofia muscular óculo-faríngea
plDystrofia oczno-gardłowa= en
csOkulofaryngeální svalová dystrofie= en
ukОкулофарингеальна мязова дистрофія= en
zh眼咽肌营养不良= en
trOkülofaringeal kas distrofisi= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM164300Evalidated
ICD-10G71.0NTBTinclusionvalidated
ICD-119C82.1NTBTindexvalidated
MONDO0008116Evalidated
MeSHD039141Evalidated
UMLSC0270952Evalidated
GARD7245Evalidated
MedDRA10052181Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PABPN1Disease-causing germline mutation(s) inAssessedHGNC:8565ENSG0000010083660227914q11.2poly(A) binding protein nuclear 120301305[PMID]
5

Prevalence and incidence

4 records
TypeClassValueAreaQualificationValidationSource
Point prevalence>1 / 1000167 / 100 000Specific populationValue and classValidated9392014[PMID]
Point prevalence1-9 / 100 0001 / 100 000FranceValue and classValidated9392013[PMID]_2204987[PMID]
Point prevalence1-9 / 100 000—EuropeClass onlyValidatedORPHANET
Point prevalence>1 / 1000100 / 100 000Specific populationValue and classValidated7795598[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

26 annotations · validated 2024-06-07
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0004303Abnormal muscle fiber morphology
HP:0002015Dysphagia
HP:0012378Fatigue
HP:0003198Myopathy
HP:0000602Ophthalmoplegia
HP:0000508Ptosis
HP:0003200Ragged-red muscle fibers
HP:0003805Rimmed vacuoles
HP:0003302Spondylolisthesis
Frequent (79-30%)
HP:0034045Angulated muscle fibers
HP:0003327Axial muscle weakness
HP:0001618Dysphonia
HP:0012548Fatty replacement of skeletal muscle
HP:0011968Feeding difficulties
HP:0003325Limb-girdle muscle weakness
HP:0100304Muscle fiber intranuclear inclusion bodies
HP:0012531Pain
HP:0032342Reduced forced expiratory volume in one second
HP:0012473Tongue atrophy
HP:0000183Tongue muscle weakness
HP:0030319Weakness of facial musculature
HP:6001011Wet voice
Occasional (29-5%)
HP:0003236Elevated circulating creatine kinase concentration
HP:0000298Mask-like facies
Very rare (<4-1%)
HP:0100543Cognitive impairment
HP:0010535Sleep apnea

Run the differential on the 9 obligate / very frequent terms

Annotation source: 20301305[PMID]_25842253[PMID]

7

Sources for this card